EA200970891A1 - Генетические варианты chr2 и chr16 в качестве маркеров для применения при оценке риска, диагностировании, прогнозировании и лечении рака молочной железы - Google Patents

Генетические варианты chr2 и chr16 в качестве маркеров для применения при оценке риска, диагностировании, прогнозировании и лечении рака молочной железы

Info

Publication number
EA200970891A1
EA200970891A1 EA200970891A EA200970891A EA200970891A1 EA 200970891 A1 EA200970891 A1 EA 200970891A1 EA 200970891 A EA200970891 A EA 200970891A EA 200970891 A EA200970891 A EA 200970891A EA 200970891 A1 EA200970891 A1 EA 200970891A1
Authority
EA
Eurasian Patent Office
Prior art keywords
breast cancer
markers
options
diagnostication
chr16
Prior art date
Application number
EA200970891A
Other languages
English (en)
Other versions
EA019953B1 (ru
Inventor
Симон Стейси
Патрик Сулем
Андрей Манолеску
Original Assignee
Декоуд Дженетикс Ехф
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Декоуд Дженетикс Ехф filed Critical Декоуд Дженетикс Ехф
Publication of EA200970891A1 publication Critical patent/EA200970891A1/ru
Publication of EA019953B1 publication Critical patent/EA019953B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Abstract

Изобретение касается определенных генетических вариантов на Chr2q14, Chr2q35 и Chrl6q12, являющихся маркерами подверженности раку молочной железы. Описываются способы оценки риска и диагностики повышенной и/или пониженной подверженности раку молочной железы с применением таких вариантов. Изобретение также относится к наборам для диагностики подверженности раку молочной железы.
EA200970891A 2007-03-26 2008-03-26 Генетические варианты chr2 и chr16 в качестве маркеров для применения при оценке риска, диагностировании, прогнозировании и лечении рака молочной железы EA019953B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS8625 2007-03-26
IS8648 2007-05-25
PCT/IS2008/000009 WO2008117314A2 (en) 2007-03-26 2008-03-26 Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment

Publications (2)

Publication Number Publication Date
EA200970891A1 true EA200970891A1 (ru) 2010-04-30
EA019953B1 EA019953B1 (ru) 2014-07-30

Family

ID=39563444

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200970891A EA019953B1 (ru) 2007-03-26 2008-03-26 Генетические варианты chr2 и chr16 в качестве маркеров для применения при оценке риска, диагностировании, прогнозировании и лечении рака молочной железы

Country Status (13)

Country Link
US (1) US20110117545A1 (ru)
EP (3) EP2137324A2 (ru)
JP (1) JP5676245B2 (ru)
KR (1) KR20090127939A (ru)
CN (1) CN101874120B (ru)
AU (1) AU2008231425B2 (ru)
CA (1) CA2681928A1 (ru)
EA (1) EA019953B1 (ru)
IL (1) IL201217A (ru)
MX (1) MX2009010439A (ru)
NZ (1) NZ580490A (ru)
WO (1) WO2008117314A2 (ru)
ZA (1) ZA200907471B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103710430B (zh) 2005-11-29 2016-03-30 剑桥企业有限公司 乳腺癌标志物
KR20110036608A (ko) 2008-07-07 2011-04-07 디코드 제네틱스 이에이치에프 유방암 위험도 평가를 위한 유전적 변이
JP2012504410A (ja) * 2008-10-03 2012-02-23 マース インコーポレーテッド イヌにおける肝臓の銅蓄積についての遺伝子検査およびペット用低銅食餌
MX2011012913A (es) * 2009-06-01 2012-02-21 Genetic Technologies Ltd Métodos para evaluar el riesgo de cáncer de mama.
US8356023B2 (en) * 2009-07-28 2013-01-15 Ancestry.Com Operations Inc. Collaborative systems and methods for constructing representations of data
EP2721180A4 (en) * 2011-06-16 2015-09-02 Decode Genetics Ehf GENETIC VARIANTS FOR PREDICTING THE RISK OF BREAST CANCER
GB201120989D0 (en) 2011-12-06 2012-01-18 Mars Inc Genetic test
KR101390590B1 (ko) * 2012-06-28 2014-04-30 서울대학교산학협력단 췌장암 재발 예후 예측용 마커 및 이의 용도
US10188617B2 (en) 2013-03-12 2019-01-29 The Board Of Trustees Of The Leland Stanford Junior University Modulation of cellular DNA repair activity to intercept malignancy
AU2015327756B2 (en) * 2014-09-30 2018-01-04 Genetic Technologies Limited Methods for assessing risk of developing breast cancer
SG11201808261RA (en) * 2016-03-29 2018-10-30 Regeneron Pharma Genetic variant-phenotype analysis system and methods of use
CN108588263B (zh) * 2018-06-07 2022-02-01 中国农业科学院烟草研究所 一种用于定位和克隆植物中控制同一性状的双隐性基因的方法
CN108676890B (zh) * 2018-07-12 2022-01-28 吉林大学 一种女性乳腺恶性肿瘤易感性预测试剂盒及系统
US10395772B1 (en) * 2018-10-17 2019-08-27 Tempus Labs Mobile supplementation, extraction, and analysis of health records
KR102091790B1 (ko) * 2019-09-02 2020-03-20 주식회사 클리노믹스 피검사자와 생물체 간의 유전자 정보를 이용한 유전적 띠 제공 시스템 및 그 방법
CA3154157A1 (en) 2019-09-13 2021-03-18 23Andme, Inc. Methods and systems for determining and displaying pedigrees

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5424186A (en) * 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5288644A (en) * 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US5858659A (en) * 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5837832A (en) * 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
AU785425B2 (en) * 2001-03-30 2007-05-17 Genetic Technologies Limited Methods of genomic analysis
EP1423535A4 (en) * 2001-08-04 2005-07-06 Whitehead Biomedical Inst HAPLOTYP CARD OF THE HUMAN GENOME AND USES THEREOF
US20040023237A1 (en) * 2001-11-26 2004-02-05 Perelegen Sciences Inc. Methods for genomic analysis
US20040146870A1 (en) * 2003-01-27 2004-07-29 Guochun Liao Systems and methods for predicting specific genetic loci that affect phenotypic traits
PL214402B1 (pl) * 2003-08-11 2013-07-31 Tomasz Byrski Zastosowanie selenu albo jego zwiazku do otrzymywania srodka do obnizania odziedziczonego ryzyka zachorowania na raka piersi lub jajnika
US9157122B2 (en) * 2004-11-11 2015-10-13 Garvan Institute Of Medical Research Method of diagnosing cancer and reagents therefor
KR101138862B1 (ko) * 2005-02-14 2012-05-14 삼성전자주식회사 단일염기 다형을 포함하는 유방암과 관련된 폴리뉴클레오티드, 그를 포함하는 마이크로어레이 및 진단 키트 및 그를이용한 유방암 진단 방법
KR101206028B1 (ko) * 2005-03-05 2012-11-28 삼성전자주식회사 유방암 특이적 다형성 서열을 이용한 유방암의 진단방법,유방암 특이적인 폴리뉴클레오티드 및 상기 폴리뉴클레오티드가 고정되어 있는 마이크로어레이
US7858303B2 (en) * 2005-03-14 2010-12-28 Wisconsin Alumni Research Foundation Method of analyzing breast cancer susceptibility and resistance
WO2006121991A2 (en) * 2005-05-06 2006-11-16 Diadexus, Inc. Compositions and methods for detection, prognosis and treatment of breast cancer

Also Published As

Publication number Publication date
MX2009010439A (es) 2009-10-20
CA2681928A1 (en) 2008-10-02
US20110117545A1 (en) 2011-05-19
AU2008231425A1 (en) 2008-10-02
WO2008117314A3 (en) 2008-12-18
WO2008117314A2 (en) 2008-10-02
IL201217A0 (en) 2010-05-31
KR20090127939A (ko) 2009-12-14
EP2527466A3 (en) 2013-05-15
EP2527466A2 (en) 2012-11-28
AU2008231425B2 (en) 2014-03-20
JP2010522555A (ja) 2010-07-08
JP5676245B2 (ja) 2015-02-25
EP2137324A2 (en) 2009-12-30
EA019953B1 (ru) 2014-07-30
EP2540840A2 (en) 2013-01-02
CN101874120A (zh) 2010-10-27
EP2540840A3 (en) 2013-05-15
IL201217A (en) 2014-03-31
CN101874120B (zh) 2015-01-14
ZA200907471B (en) 2014-03-26
NZ580490A (en) 2012-08-31

Similar Documents

Publication Publication Date Title
EA200970891A1 (ru) Генетические варианты chr2 и chr16 в качестве маркеров для применения при оценке риска, диагностировании, прогнозировании и лечении рака молочной железы
EA200971079A1 (ru) ГЕНЕТИЧЕСКИЕ ВАРИАНТЫ В Chr5p12 И 10q26 В КАЧЕСТВЕ МАРКЕРОВ ДЛЯ ПРИМЕНЕНИЯ ПРИ ОЦЕНКЕ РИСКА, ДИАГНОСТИРОВАНИИ, ПРОГНОЗИРОВАНИИ И ЛЕЧЕНИИ РАКА ГРУДИ
WO2012006589A3 (en) Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
CY1116967T1 (el) Συνθεσεις και μεθοδοι για θεραπευτικη αγωγη και διαγνωση καρκινου
MX2009012625A (es) Metodos para el tratamiento, diagnostico y deteccion de trastornos asociados con el fgf21.
EA201490029A1 (ru) Соединения, ингибирующие металлоферменты
WO2010017515A3 (en) Breast cancer specific markers and methods of use
EA201171367A1 (ru) Винилиндазолильные соединения
EA201590630A1 (ru) Способы лечения и диагностики, связанные с лизилоксидазоподобным белком 2 (loxl2)
NO20091661L (no) Anvendelse av pegylert IL-10 for a behandle kreft
HK1145342A1 (en) Prognosis prediction for melanoma cancer
WO2010004591A3 (en) Genetic variants for breast cancer risk assessment
WO2008120098A3 (en) Peptide prodrugs
WO2010004590A3 (en) Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
WO2009015050A3 (en) Gene expression profile for predicting ovarian cancer patient survival
BR112014031414A2 (pt) métodos de detectar doenças ou condições utilizando células doentes circulantes
BRPI0813364A2 (pt) Métodos de diagnóstico e tratamento de câncer.
EA201590650A1 (ru) Антиандрогены для лечения неметастатического кастрационно-резистентного рака простаты
EP3736022A3 (en) Treatment and diagnosis of colon cancer
MY155340A (en) Use of cathepsin c
EP1987165A4 (en) Gene with influence on the human memory
WO2008092002A3 (en) Compositions and methods for treating and diagnosing pancreatic cancer
WO2009105457A3 (en) Slit2 cancer markers
MX2010001571A (es) Marcador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU